drugset / Trial / NCT00758433

Civamide Patch Safety, Tolerability and PK Study

NCT00758433 ↗

Phase 1 Completed 39 enrolled Winston Laboratories
RandomizedParallel-groupQuadruple-blindBasic science

Summary

To evaluate the tolerability of two different strengths of a Civamide Patch (0.0075% and 0.0150%) compared to the placebo patch and each other in healthy adult volunteers. To assess the pharmacokinetics of civamide and to determine if there is systemic absorption of the drug from civamide patch in a subset of study subjects.

Timeline

Start
2008-09
Primary completion
2008-12
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Zucapsaicin Small molecule 0.0075 % Topical
Comparator Zucapsaicin Small molecule 0.015 % Topical

Indications

No indication recorded.